Serious/Rare Risks: Pancreatitis, gallbladder issues (a known risk with rapid weight loss), and modest increases in resting heart rate
As the clock ticks down on compliance deadlines, it is critical that compounding pharmacies and telehealth companies that prescribe GLP-1 medications review their practices, including pharmacy relationships, drug fulfillment, and patient-facing materials, to ensure they are prepared to adhere to the FDAs regulations for semaglutide and other compounded drugs
Key Takeaways MOTS-c is a mitochondrial-derived peptide involved in regulating metabolic homeostasis, improving insulin sensitivity, and enhancing mitochondrial function, primarily studied in preclinical models
Shed offers GLP-1 liquid drops, lozenges, and the oral Wegovy pill as needle-free alternatives to injectable formats, subject to state availability and provider approval
The 2024 average rate of AOM semaglutide prescriptions for adolescents with obesity within 100 days of an encounter was 0.9%